超声上可疑肿块伴高回声环:乳腺癌诊断效能及与病理肿瘤特征的相关性
这项回顾性研究纳入511例患者583个BI-RADS 4或5类可疑肿块,评估高回声环(环周范围≥25%)诊断乳腺癌的效能及其与病理特征的相关性。高回声环诊断乳腺癌的敏感度为58%和51%、特异度为81%和85%,与浸润性癌及其分子亚型相关,纳入高回声环测量可减少肿瘤大小低估。
要点
- 高回声环诊断乳腺癌特异度(81%/85%)高于敏感度(58%/51%)。
- 高回声环与浸润性癌相关,导管原位癌中少见。
- 测量肿块时纳入高回声环可减少与病理大小的低估差异。
核心结论
- 高回声环是乳腺癌特异性高于敏感性的指标。
- 在乳腺癌中,高回声环与浸润性癌相关。
- 纳入高回声环测量可减少相对于手术病理的肿瘤大小低估。
研究设计与样本
- 回顾性研究,纳入2022年7月1日至2023年6月30日期间接受诊断性乳腺超声显示可疑肿块(BI-RADS 4或5类)并随后行超声引导下活检的患者。
- 共511例患者(平均年龄52岁)、583个可疑肿块,其中249个诊断为乳腺癌。
- 两名放射科医生独立审阅超声图像,评估肿块相关高回声环(要求环周范围≥25%),并分别测量不纳入和纳入高回声环的肿块大小。
- 以组织病理学为参考标准评估诊断效能。
关键影像表现/征象
- 高回声环定义为部分或完全环绕肿块、破坏周围组织纹理的厚高回声带。
- 168个切除的恶性肿瘤中,病理肿瘤大小均值19 mm,与超声肿块大小的差异在不纳入和纳入高回声环时分别为阅片者1的4 mm和3 mm、阅片者2的7 mm和5 mm。
诊断标准与关键数值
- 高回声环诊断乳腺癌的敏感度和特异度分别为阅片者1的58%和81%、阅片者2的51%和85%。
- 高回声环与浸润性癌相关:阅片者1浸润性导管癌62%、浸润性小叶癌57%、导管原位癌24%(p=.003);阅片者2浸润性导管癌53%、浸润性小叶癌53%、导管原位癌18%(p=.03)。
- 高回声环与浸润性癌分子亚型相关:阅片者1 luminal A型66%、luminal B型48%、HER2富集型100%、基底样型25%(p=.002);阅片者2 luminal A型62%、luminal B型32%、HER2富集型67%、基底样型19%(p<.001)。
临床应用与阅片要点
- 高回声环可作为提示乳腺癌的关联特征,其特异度高于敏感度。
- 在乳腺癌中,高回声环提示浸润性癌可能。
- 测量肿块时纳入高回声环可减少肿瘤大小低估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. The 6th edition of the BI-RADS ultrasound lexicon is anticipated to include echogenic rind as a renamed associated feature, defined as a thick hyperechoic band partially or completely surrounding a mass and disrupting surrounding tissue texture. OBJECTIVE. The purpose of this study was to assess the performance of an echogenic rind associated with a suspicious mass on breast ultrasound for breast malignancy diagnosis as well as associations of echogenic rind with pathologic tumor characteristics. METHODS. This retrospective study included patients who underwent both diagnostic breast ultrasound that showed a suspicious mass (BI-RADS category 4 or 5) and subsequent ultrasound-guided biopsy from July 1, 2022, to June 30, 2023. Two radiologists independently reviewed the ultrasound examinations for echogenic rinds (requiring circumferential extent ≥ 25%) associated with masses; the readers also measured masses without and with inclusion of echogenic rinds. Diagnostic performance was evaluated using histopathology as the reference. RESULTS. The study included 511 patients (mean age, 52 years) with 583 suspicious masses; 249 masses were diagnosed as breast malignancy. The presence of echogenic rind yielded sensitivity and specificity, respectively, for breast malignancy of 58% and 81% for reader 1 and 51% and 85% for reader 2. An echogenic rind was associated with invasive cancer for reader 1 (invasive ductal carcinoma [IDC], 62%; invasive lobular carcinoma [ILC], 57%; ductal carcinoma in situ [DCIS], 24%; p = .003) and reader 2 (IDC, 53%; ILC, 53%; DCIS, 18%; p = .03). An echogenic rind was associated with invasive cancer molecular subtype for reader 1 (luminal A, 66%; luminal B, 48%; HER2-enriched, 100%; basal-like, 25%; p = .002) and reader 2 (luminal A, 62%; luminal B, 32%; HER2-enriched, 67%; basal-like, 19%; p < .001). In 168 resected malignancies, the difference between pathologic tumor size (mean, 19 mm) and ultrasound-based mass size, without and with the inclusion of echogenic rinds, was 4 and 3 mm for reader 1 and 7 and 5 mm for reader 2, respectively. CONCLUSION. An echogenic rind serves as a more specific than sensitive indicator of breast malignancy. Among breast malignancies, the finding is associated with invasive cancer. Inclusion of the rind decreases underestimation of tumor size relative to surgical pathology. CLINICAL IMPACT. These results provide insights into the clinical implications of an echogenic rind on ultrasound.
引用
- Nguyen DL, Grimm LJ, Wells VA, et al. Echogenic Rind Associated With Suspicious Masses on Ultrasound: Performance for Breast Cancer Diagnosis and Associations With Pathologic Tumor Characteristics. AJR Am J Roentgenol. 2025. PMID: 40960244. doi:10.2214/AJR.25.33732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。